386 Complete/near-complete itch response observed in adult and adolescent patients with moderate-to-severe atopic dermatitis initiating dupilumab treatment in real-world practice

被引：0
|
作者：
Bhatia, Neal [1 ]
Lynde, Charles W. [2 ,3 ]
Fonacier, Luz [4 ,5 ]
Tian, Tingting [6 ]
Bosman, Kwinten [7 ]
Korotzer, Andrew [6 ]
机构：
[1] Therapeut Clin Res, San Diego, CA USA
[2] Univ Toronto, Markham, ON, Canada
[3] Lynderm Res, Markham, ON, Canada
[4] New York Univ, Langone Hosp Long Isl, Mineola, NY USA
[5] New York Univ, Long Isl Sch Med, Mineola, NY USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Sanofi, Amsterdam, Netherlands
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷
关键词：
real-world; registry; dupilumab; pruritus;
D O I：
10.1093/bjd/ljad162.013
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
386
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Dupilumab treatment significantly improves skin barrier function in adult and adolescent patients with moderate to severe atopic dermatitis
    Iversen, L.
    Conrad, C.
    Karner, J.
    Costanzo, A.
    Cardner, M.
    Bier, K.
    Lohmann, F.
    Kolbinger, F.
    Jagiello, P.
    Ferrero, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S243 - S243
  • [42] Real-world effectiveness and safety of dupilumab in patients with moderate and severe atopic dermatitis: 2-year experience
    Fujiwara, Chisako
    Uchiyama, Akihiko
    Inoue, Yuta
    Ishikawa, Mai
    Motegi, Sei-ichiro
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (03) : 88 - 93
  • [43] Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study
    Berna-Rico, Emilio
    Fiz-Benito, Esther
    Busto-Leis, Jose Manuel
    Servera-Negre, Guillermo
    de Lucas-Laguna, Raul
    Feito-Rodriguez, Marta
    DERMATOLOGY, 2024, 240 (02) : 337 - 342
  • [44] Long-term efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a prospective real-world cohort study in China
    Wang, Yuyi
    Jia, Ruiling
    Hu, Qin
    Tao, Xiao
    He, Qi
    Luo, Guangying
    Xiong, Qiong
    Zhang, Zhongyu
    Xiao, Yujuan
    Liu, Yi
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [45] Onset and maintenance of optimal itch response in adult patients with moderate-to-severe atopic dermatitis treated with dupilumab: post hoc analysis from LIBERTY AD CHRONOS
    Staender, Sonja
    Yosipovitch, Gil
    Simpson, Eric L.
    Kim, Brian S.
    Kabashima, Kenji
    Thaci, Diamant
    Metz, Martin
    Chen, Zhen
    Hagen, Sandra
    Bastian, Mike
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [46] Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus
    Luigi Gargiulo
    Luciano Ibba
    Piergiorgio Malagoli
    Anna G. Burroni
    Andrea Chiricozzi
    Paolo Dapavo
    Silvia M. Ferrucci
    Massimo Gola
    Maddalena Napolitano
    Michela Ortoncelli
    Maria T. Rossi
    Claudio Sciarrone
    Antonio Costanzo
    Alessandra Narcisi
    Dermatology and Therapy, 2024, 14 : 919 - 932
  • [47] Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus
    Gargiulo, Luigi
    Ibba, Luciano
    Malagoli, Piergiorgio
    Burroni, Anna G.
    Chiricozzi, Andrea
    Dapavo, Paolo
    Ferrucci, Silvia M.
    Gola, Massimo
    Napolitano, Maddalena
    Ortoncelli, Michela
    Rossi, Maria T.
    Sciarrone, Claudio
    Costanzo, Antonio
    Narcisi, Alessandra
    DERMATOLOGY AND THERAPY, 2024, 14 (04) : 919 - 932
  • [48] Dupilumab treatment provides long-term improvement in itch in pediatric patients with moderate-to-severe atopic dermatitis over 1 year
    Siegfried, Elaine
    Simpson, Eric L.
    Boguniewicz, Mark
    Flohr, Carsten
    Eichenfield, Lawrence F.
    Pinter, Andreas
    Ramien, Michele
    Gao, Xing-Hua
    Chen, Zhen
    Bates, Lauren
    Rossi, Ana B.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II56 - II57
  • [49] Treatment satisfaction with long-term dupilumab treatment in adult patients with moderate-to-severe atopic dermatitis (LIBERTY AD OLE)
    Thaci, D.
    Blauvelt, A.
    Hussain, I
    Bastian, M.
    Sun, X.
    Chao, J.
    Levit, N. A.
    Rossi, A. B.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 65 - 65
  • [50] A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis
    Fargnoli, M. C.
    Esposito, M.
    Ferrucci, S.
    Girolomoni, G.
    Offidani, A.
    Patrizi, A.
    Peris, K.
    Costanzo, A.
    Malara, G.
    Pellacani, G.
    Romanelli, M.
    Amerio, P.
    Cristaudo, A.
    Flori, M. L.
    Motolese, A.
    Betto, P.
    Patruno, C.
    Pigatto, P.
    Peccianti, C.
    Stinco, G.
    Zalaudek, I.
    Bianchi, L.
    Boccaletti, V.
    Cannavo, S. P.
    Cusano, F.
    Lembo, S.
    Mozzillo, R.
    Gallo, R.
    Potenza, C.
    Rongioletti, F.
    Tiberio, R.
    Grieco, T.
    Micali, G.
    Persechino, S.
    Pettinato, M.
    Pucci, S.
    Stingeni, L.
    Caruso, C.
    Argenziano, G.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 1146 - 1149
12345